BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11398794)

  • 1. API2-MALT1 chimeric transcript is a predictive marker for the responsiveness of H. pylori eradication treatment in low-grade gastric MALT lymphoma.
    Sugiyama T; Asaka M; Nakamura T; Nakamura S; Yonezumi S; Seto M
    Gastroenterology; 2001 Jun; 120(7):1884-5. PubMed ID: 11398794
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinicopathologic comparison between the API2-MALT1 chimeric transcript-positive and -negative gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type.
    Nakamura T; Nakamura S; Yokoi T; Suzuki H; Ohashi K; Seto M
    Jpn J Cancer Res; 2002 Jun; 93(6):677-84. PubMed ID: 12079516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
    Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
    Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to Helicobacter pylori and CagA protein are associated with the response to antibacterial therapy in patients with H. pylori-positive API2-MALT1-negative gastric MALT lymphoma.
    Sumida T; Kitadai Y; Hiyama T; Shinagawa K; Tanaka M; Kodama M; Masuda H; Ito M; Tanaka S; Yoshihara M; Chayama K
    Cancer Sci; 2009 Jun; 100(6):1075-81. PubMed ID: 19385974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric MALT lymphomas are divided into three groups based on responsiveness to Helicobacter Pylori eradication and detection of API2-MALT1 fusion.
    Inagaki H; Nakamura T; Li C; Sugiyama T; Asaka M; Kodaira J; Iwano M; Chiba T; Okazaki K; Kato A; Ueda R; Eimoto T; Okamoto S; Sasaki N; Uemura N; Akamatsu T; Miyabayashi H; Kawamura Y; Goto H; Niwa Y; Yokoi T; Seto M; Nakamura S
    Am J Surg Pathol; 2004 Dec; 28(12):1560-7. PubMed ID: 15577674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori-negative / API2-MALT1 translocation-negative low-grade MALT lymphoma.
    Nozaki K; Nomura S; Shimizu N; Hiki N; Yoshizawa N; Aikou S; Kubota K; Yamaguchi H; Kurosaka H; Shinozaki A; Mafune K; Fukayama M; Kaminishi M
    Gastric Cancer; 2006; 9(3):229-34. PubMed ID: 16952043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric low-grade B-cell MALT lymphoma: treatment, response, and genetic alteration.
    Nakamura T; Inagaki H; Seto M; Nakamura S
    J Gastroenterol; 2003; 38(10):921-9. PubMed ID: 14614598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of non-Helicobacter pylori helicobacter infections in Helicobacter pylori-negative gastric MALT lymphoma pathogenesis and efficacy of eradication therapy.
    Takigawa H; Yuge R; Masaki S; Otani R; Kadota H; Naito T; Hayashi R; Urabe Y; Oka S; Tanaka S; Chayama K; Kitadai Y
    Gastric Cancer; 2021 Jul; 24(4):937-945. PubMed ID: 33638751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review.
    Asano N; Iijima K; Koike T; Imatani A; Shimosegawa T
    World J Gastroenterol; 2015 Jul; 21(26):8014-20. PubMed ID: 26185372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication.
    Liu H; Ye H; Ruskone-Fourmestraux A; De Jong D; Pileri S; Thiede C; Lavergne A; Boot H; Caletti G; Wündisch T; Molina T; Taal BG; Elena S; Thomas T; Zinzani PL; Neubauer A; Stolte M; Hamoudi RA; Dogan A; Isaacson PG; Du MQ
    Gastroenterology; 2002 May; 122(5):1286-94. PubMed ID: 11984515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
    Begum S; Sano T; Endo H; Kawamata H; Urakami Y
    J Med Invest; 2000 Feb; 47(1-2):36-46. PubMed ID: 10740978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma.
    Streubel B; Ye H; Du MQ; Isaacson PG; Chott A; Raderer M
    Oncology; 2004; 66(6):476-80. PubMed ID: 15452377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of gastric mucosa-associated lymphoid tissue lymphoma in patients with extra copies of the
    Iwamuro M; Takenaka R; Nakagawa M; Moritou Y; Saito S; Hori S; Inaba T; Kawai Y; Toyokawa T; Tanaka T; Yoshino T; Okada H
    World J Gastroenterol; 2017 Sep; 23(33):6155-6163. PubMed ID: 28970731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin VH gene analysis in gastric MALT lymphomas.
    Sakuma H; Nakamura T; Uemura N; Chiba T; Sugiyama T; Asaka M; Akamatsu T; Ueda R; Eimoto T; Goto H; Nakamura S; Inagaki H
    Mod Pathol; 2007 Apr; 20(4):460-6. PubMed ID: 17334352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of caspase recruitment domain (CARD) membrane-associated guanylate kinase 1 (CARMA1) and CARD9 in primary gastric B-cell lymphoma.
    Nakamura S; Nakamura S; Matsumoto T; Yada S; Hirahashi M; Suekane H; Yao T; Goda K; Iida M
    Cancer; 2005 Nov; 104(9):1885-93. PubMed ID: 16177990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan.
    Nakamura S; Sugiyama T; Matsumoto T; Iijima K; Ono S; Tajika M; Tari A; Kitadai Y; Matsumoto H; Nagaya T; Kamoshida T; Watanabe N; Chiba T; Origasa H; Asaka M;
    Gut; 2012 Apr; 61(4):507-13. PubMed ID: 21890816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary gastric lymphoma.
    Isaacson PG
    Br J Biomed Sci; 1995 Dec; 52(4):291-6. PubMed ID: 8555783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori and the t(11;18)(q21;q21) translocation in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type.
    Nakamura T; Nakamura S; Yonezumi M; Suzuki T; Matsuura A; Yatabe Y; Yokoi T; Ohashi K; Seto M
    Jpn J Cancer Res; 2000 Mar; 91(3):301-9. PubMed ID: 10760689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of gastric B-cell lymphoma of mucosa-associated lymphoid tissue type involving multiple organs.
    Iwano M; Okazaki K; Uchida K; Nakase H; Ohana M; Matsushima Y; Inagaki H; Chiba T
    J Gastroenterol; 2004 Aug; 39(8):739-46. PubMed ID: 15338367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome.
    Choi YJ; Kim N; Paik JH; Kim JM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC
    Helicobacter; 2013 Jun; 18(3):197-205. PubMed ID: 23305046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.